🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To monitor the safety profile and efficacy of GIOTRIF® (afatinib dimaleate,...
Status
Completed
Location
Multiple Locations
Start Date
2014-10-31
Trial ID
NCT02285361
Treatments Being Tested
The objective of the Phase I step is to estimate the MTD at a dose level up...
Status
Completed
Location
1200.33.010 Boehringer Ingelheim Investigational Site
Start Date
2008-04
Trial ID
NCT00711594
Treatments Being Tested
In Japan, post-approval execution of post marketing surveillance (PMS) is r...
Status
Completed
Location
Boehringer Ingelheim Investigational Site 145
Start Date
2014-05-07
Trial ID
NCT02131259
Treatments Being Tested
The purpose of this study is to examine the efficacy and safety of using af...
Status
Completed
Location
Royal Bournemouth Hospital
Start Date
2012-12
Trial ID
NCT01415011
Treatments Being Tested
Despite recent advances, the prognosis of patients with advanced gastric ca...
Status
Recruiting
Location
Samsung Medical Center
Start Date
2024-09-30
Trial ID
NCT06085755
Treatments Being Tested
Non-interventional, multi-country, multi-centre cohort study based on exist...
Status
Completed
Location
Royal Marsden Hospital
Start Date
2019-12-17
Trial ID
NCT04179890
The purpose of this Phase I study is to test the safety of combining afatin...
Status
Withdrawn
Location
Multiple Locations
Start Date
2013-04
Trial ID
NCT01836341
Treatments Being Tested
The aim of the COMBINATION trial is to prospectively study the sequential a...
Status
Completed
Location
Amsterdam UMC, location VUmc
Start Date
2022-01-04
Trial ID
NCT05298176
Treatments Being Tested
* To identify the Maximum Tolerated Dose (MTD) of afatinib in combination w...
Status
Completed
Location
1200.84.003 Boehringer Ingelheim Investigational Site
Start Date
2010-10-01
Trial ID
NCT01214616
Treatments Being Tested
To assess if targeting activating EGFR and HER2 mutations in Non-Small Cell...
Status
Completed
Location
Aberdeen Royal Infirmary (NHS Grampian)
Start Date
2016-12-16
Trial ID
NCT02183883
Treatments Being Tested